• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

握力与小腿围度联合作为肝病患者的有效预后评估系统:一项大型队列研究

Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.

作者信息

Nishikawa Hiroki, Yoh Kazunori, Enomoto Hirayuki, Nishimura Takashi, Nishiguchi Shuhei, Iijima Hiroko

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Center for Clinical Research and Education, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

出版信息

Ann Transl Med. 2021 Apr;9(8):624. doi: 10.21037/atm-20-6901.

DOI:10.21037/atm-20-6901
PMID:33987322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105999/
Abstract

BACKGROUND

Sarcopenia and body composition can be associated with mortality in chronic liver diseases (CLDs). We sought to identify predictors in CLD patients (n=631, 309 males) and create a prognostic model using easily available indexes.

METHODS

Reference values for low-grip strength (GS) were 26 kg in men and 18 kg in women. Reference values for low-skeletal muscle index (SMI) were 7.0 kg/m in men and 5.7 kg/m in women using bioelectrical impedance analysis (BIA). Reference values for low-calf circumference (CC) were 34 cm in men and 33 cm in women. Reference values for high-waist circumference were 85 cm in men and 90 cm in women. Using significant factors in the multivariate analysis contributing to the overall survival (OS), we created a simple predictive model. Akaike information criterion (AIC) was compared.

RESULTS

Men (P<0.0001), presence of liver cirrhosis (LC) (P<0.0001), presence of hepatocellular carcinoma (HCC) (P<0.0001), low-GS (P<0.0001), low-CC (P<0.0001), serum albumin (P=0.0355), estimated glomerular filtration rate (P=0.0461), hepatitis B virus (P=0.0044) and hepatitis C virus (P<0.0001) were significant factors contributing to the OS by the multivariate analysis. The study subjects were classified into the 4 groups (combined GS-SMI system): (I) low-GS and low-SMI (sarcopenia, n=73); (II) low-GS and high-SMI (n=65); (III) high-GS and low-SMI (n=110); and (IV) high-GS and high-SMI (n=383). The cumulative OS rates were well stratified among 4 groups (overall P<0.0001, AIC =360.895). The study subjects were also classified into the 4 groups (combined GS-CC system): (I) low-GS and low-CC (n=60); (II) low-GS and high-CC (n=78); (III) high-GS and low-CC (n=70); and (IV) high-GS and high-CC (n=423). The cumulative OS rates were also well stratified among 4 groups (overall P<0.0001, AIC =349.521). In receiver operating characteristic (ROC) curve analysis for CC based on the OS, the optimal cutoff point in men was 34.6 cm [area under the ROC (AUC) =0.70, sensitivity =0.558, specificity =0.842], and that in women was 32.8 cm (AUC =0.72, sensitivity =0.619, specificity =0.787).

CONCLUSIONS

CC can be an alternative marker for muscle mass in CLD patients. Our proposed combined GS-CC system can be helpful in the community settings without special equipment for muscle mass measurement.

摘要

背景

肌肉减少症和身体组成可能与慢性肝病(CLD)患者的死亡率相关。我们试图确定CLD患者(n = 631,309名男性)的预测因素,并使用易于获得的指标创建一个预后模型。

方法

男性低握力(GS)的参考值为26千克,女性为18千克。使用生物电阻抗分析(BIA),男性低骨骼肌指数(SMI)的参考值为7.0千克/米,女性为5.7千克/米。男性低小腿围(CC)的参考值为34厘米,女性为33厘米。男性高腰围的参考值为85厘米,女性为90厘米。利用多变量分析中对总生存期(OS)有影响的显著因素,我们创建了一个简单的预测模型。比较了赤池信息准则(AIC)。

结果

男性(P<0.0001)、肝硬化(LC)的存在(P<0.0001)、肝细胞癌(HCC)的存在(P<0.0001)、低GS(P<0.0001)、低CC(P<0.0001)、血清白蛋白(P = 0.0355)、估计肾小球滤过率(P = 0.0461)、乙型肝炎病毒(P = 0.0044)和丙型肝炎病毒(P<0.0001)是多变量分析中对OS有显著影响的因素。研究对象被分为4组(联合GS-SMI系统):(I)低GS和低SMI(肌肉减少症,n = 73);(II)低GS和高SMI(n = 65);(III)高GS和低SMI(n = 110);以及(IV)高GS和高SMI(n = 383)。4组之间的累积OS率有良好的分层(总体P<0.0001,AIC = 360.895)。研究对象也被分为4组(联合GS-CC系统):(I)低GS和低CC(n = 60);(II)低GS和高CC(n = 78);(III)高GS和低CC(n = 70);以及(IV)高GS和高CC(n = 423)。4组之间的累积OS率也有良好的分层(总体P<0.0001,AIC = 349.521)。在基于OS的CC的受试者工作特征(ROC)曲线分析中,男性的最佳截断点为34.6厘米[ROC曲线下面积(AUC)= 0.70,灵敏度 = 0.558,特异性 = 0.842],女性为32.8厘米(AUC = 0.72,灵敏度 = 0.619,特异性 = 0.787)。

结论

CC可以作为CLD患者肌肉量的替代标志物。我们提出的联合GS-CC系统在没有测量肌肉量的特殊设备的社区环境中可能会有所帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/62a10b0bb75a/atm-09-08-624-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/ebea304b0098/atm-09-08-624-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/cd79b9b66a26/atm-09-08-624-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/bc7c9fb56348/atm-09-08-624-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/e81eebf202c2/atm-09-08-624-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/1c955c6ea2df/atm-09-08-624-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/2945bd300522/atm-09-08-624-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/29bfe549f24b/atm-09-08-624-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/62a10b0bb75a/atm-09-08-624-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/ebea304b0098/atm-09-08-624-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/cd79b9b66a26/atm-09-08-624-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/bc7c9fb56348/atm-09-08-624-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/e81eebf202c2/atm-09-08-624-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/1c955c6ea2df/atm-09-08-624-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/2945bd300522/atm-09-08-624-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/29bfe549f24b/atm-09-08-624-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/013d/8105999/62a10b0bb75a/atm-09-08-624-f8.jpg

相似文献

1
Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.握力与小腿围度联合作为肝病患者的有效预后评估系统:一项大型队列研究
Ann Transl Med. 2021 Apr;9(8):624. doi: 10.21037/atm-20-6901.
2
Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.小腿围度可作为预测肝病患者肌肉减少症的有用指标。
In Vivo. 2020 Sep-Oct;34(5):2561-2569. doi: 10.21873/invivo.12073.
3
Calf Circumference as a Simple Screening Marker for Diagnosing Sarcopenia in Older Korean Adults: the Korean Frailty and Aging Cohort Study (KFACS).小腿围作为一种简单的筛查标志物,用于诊断韩国老年成年人的肌肉减少症:韩国虚弱和老龄化队列研究(KFACS)。
J Korean Med Sci. 2018 Apr 26;33(20):e151. doi: 10.3346/jkms.2018.33.e151. eCollection 2018 May 14.
4
Anthropometric Measurements and Frailty in Patients with Liver Diseases.肝病患者的人体测量与衰弱
Diagnostics (Basel). 2020 Jun 25;10(6):433. doi: 10.3390/diagnostics10060433.
5
Validity of calf circumference for estimating skeletal muscle mass for Asian patients after stroke.小腿围度评估亚洲脑卒中患者骨骼肌量的有效性。
Nutrition. 2021 Feb;82:111028. doi: 10.1016/j.nut.2020.111028. Epub 2020 Sep 25.
6
Skeletal Muscle Mass by Bioelectrical Impedance Analysis and Calf Circumference for Sarcopenia Diagnosis.通过生物电阻抗分析和小腿围度诊断肌肉减少症的骨骼肌质量
J Electr Bioimpedance. 2020 Jul 24;11(1):57-61. doi: 10.2478/joeb-2020-0009. eCollection 2020 Jan.
7
Calf circumference predicts sarcopenia in maintenance hemodialysis.小腿围预测维持性血液透析患者的肌肉减少症。
Nutr Clin Pract. 2024 Feb;39(1):193-201. doi: 10.1002/ncp.11089. Epub 2023 Nov 6.
8
Reduced grip strength is associated with progression of depressive status in chronic liver diseases.握力下降与慢性肝病患者抑郁状态的进展有关。
Ann Palliat Med. 2021 Apr;10(4):3976-3987. doi: 10.21037/apm-20-2059. Epub 2021 Mar 22.
9
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.骨骼肌量迅速下降预示经导管肝动脉内治疗的肝细胞癌预后不良。
BMC Cancer. 2018 Jul 24;18(1):756. doi: 10.1186/s12885-018-4673-2.
10
Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases.在慢性肝病患者中,肌肉减少症相关的肌无力而非肌少症与代谢综合征有关。
Diagnostics (Basel). 2021 Jul 14;11(7):1262. doi: 10.3390/diagnostics11071262.

引用本文的文献

1
Risk of subsequent gastrointestinal disease assessed by skeletal muscle strength and mass in a prospective cohort study.一项前瞻性队列研究中通过骨骼肌力量和质量评估后续胃肠道疾病的风险。
iScience. 2024 Mar 5;27(4):109341. doi: 10.1016/j.isci.2024.109341. eCollection 2024 Apr 19.
2
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance.慢性病毒性肝炎中的肌肉减少症:从概念到临床意义
World J Hepatol. 2023 May 27;15(5):649-665. doi: 10.4254/wjh.v15.i5.649.
3
Calf Circumference, a Valuable Tool to Predict Sarcopenia in Older People Hospitalized with Hip Fracture.

本文引用的文献

1
Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update.日本肝脏学会乙型肝炎病毒感染管理指南:2019年更新版
Hepatol Res. 2020 Aug;50(8):892-923. doi: 10.1111/hepr.13504. Epub 2020 Jul 15.
2
Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases.握力:慢性肝病患者肝脏复合事件的有用标志物。
Diagnostics (Basel). 2020 Apr 20;10(4):238. doi: 10.3390/diagnostics10040238.
3
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.
小腿围:预测老年髋部骨折住院患者肌少症的有用工具
Nutrients. 2022 Oct 12;14(20):4255. doi: 10.3390/nu14204255.
4
Calf Circumference and All-Cause Mortality: A Systematic Review and Meta-Analysis Based on Trend Estimation Approaches.小腿围与全因死亡率:基于趋势估计方法的系统评价和荟萃分析。
J Nutr Health Aging. 2022;26(9):826-838. doi: 10.1007/s12603-022-1838-0.
5
Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease.慢性肝病中肌肉减少症和骨质疏松性肌肉减少症的影响因素及分子发病机制
Life (Basel). 2021 Aug 30;11(9):899. doi: 10.3390/life11090899.
亚洲肌少症工作组:2019年肌少症诊断与治疗共识更新
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.
4
Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts.与肥胖和与肝脏相关死亡率风险相比,身体活动:来自两个前瞻性、全国性队列的结果。
J Hepatol. 2020 Jun;72(6):1062-1069. doi: 10.1016/j.jhep.2019.12.022. Epub 2020 Jan 15.
5
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.亚太地区的肝脏疾病:《柳叶刀·胃肠病学和肝脏病学》专刊。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228. doi: 10.1016/S2468-1253(19)30342-5. Epub 2019 Dec 15.
6
Disease-Related Malnutrition and Sarcopenia as Determinants of Clinical Outcome.疾病相关营养不良和肌肉减少症作为临床结局的决定因素
Visc Med. 2019 Oct;35(5):282-291. doi: 10.1159/000502867. Epub 2019 Sep 2.
7
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.综述文章:肝硬化患者的营养不良/肌肉减少症和衰弱。
Aliment Pharmacol Ther. 2020 Jan;51(1):64-77. doi: 10.1111/apt.15571. Epub 2019 Nov 8.
8
Hepatitis C.丙型肝炎。
Lancet. 2019 Oct 19;394(10207):1451-1466. doi: 10.1016/S0140-6736(19)32320-7.
9
Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients.肝硬化患者的衰弱、肌肉减少症和营养不良。
Clin Liver Dis. 2019 Nov;23(4):589-605. doi: 10.1016/j.cld.2019.06.001. Epub 2019 Aug 21.
10
MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.MELD-GRAIL-Na:肝移植等待名单上的肾小球滤过率和死亡率。
Hepatology. 2020 May;71(5):1766-1774. doi: 10.1002/hep.30932. Epub 2020 Jan 29.